"Time-to-Treatment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The interval of time between onset of symptoms and receiving therapy.
Descriptor ID |
D061665
|
MeSH Number(s) |
E02.760.928 N02.421.585.928
|
Concept/Terms |
Time-to-Treatment- Time-to-Treatment
- Time-to-Treatments
- Time to Treatment
- Time to Treatments
- Treatment, Time to
- Treatments, Time to
Door-to-Treatment Time- Door-to-Treatment Time
- Door to Treatment Time
- Door-to-Treatment Times
- Time, Door-to-Treatment
- Times, Door-to-Treatment
|
Below are MeSH descriptors whose meaning is more general than "Time-to-Treatment".
Below are MeSH descriptors whose meaning is more specific than "Time-to-Treatment".
This graph shows the total number of publications written about "Time-to-Treatment" by people in this website by year, and whether "Time-to-Treatment" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 1 | 1 | 2 |
2014 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2016 | 3 | 4 | 7 |
2017 | 43 | 35 | 78 |
2018 | 35 | 58 | 93 |
2019 | 16 | 25 | 41 |
2020 | 39 | 77 | 116 |
2021 | 25 | 37 | 62 |
To return to the timeline, click here.
Below are the most recent publications written about "Time-to-Treatment" by people in Profiles.
-
Infarction code in a cardiac intermediate care unit during COVID-19 pandemic Arch Cardiol Mex. 2021 Dec 20; 91(Suplemento COVID):134-137.
-
OUTCOMES IN PATIENTS RESUMING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOLLOWING TREATMENT DELAY DURING THE CORONAVIRUS-19 PANDEMIC. Retina. 2021 12 01; 41(12):2456-2461.
-
Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study. Br J Surg. 2021 11 11; 108(11):1270-1273.
-
Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling. J Natl Cancer Inst. 2021 11 02; 113(11):1484-1494.
-
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors. Cancer Discov. 2021 10; 11(10):2430-2435.
-
Impact of COVID-19 pandemic on functional urology procedures in France: a prospective study. World J Urol. 2022 Jan; 40(1):277-282.
-
Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions. Proc Natl Acad Sci U S A. 2021 08 31; 118(35).
-
Tracheostomy for COVID-19: evolving best practice. Crit Care. 2021 08 31; 25(1):316.
-
Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models. Int J Stroke. 2021 Oct; 16(7):771-783.
-
Comparative study on the clinical characteristics of local cases of COVID-19 and imported cases from abroad: A retrospective cohort study. Medicine (Baltimore). 2021 Aug 27; 100(34):e26933.